Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Debt (2016 - 2025)

Historic Total Debt for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $834.9 million.

  • Conmed's Total Debt fell 782.08% to $834.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $834.9 million, marking a year-over-year decrease of 782.08%. This contributed to the annual value of $834.9 million for FY2025, which is 782.08% down from last year.
  • Conmed's Total Debt amounted to $834.9 million in Q4 2025, which was down 782.08% from $853.8 million recorded in Q3 2025.
  • In the past 5 years, Conmed's Total Debt registered a high of $1.1 billion during Q1 2023, and its lowest value of $684.7 million during Q4 2021.
  • Its 5-year average for Total Debt is $901.2 million, with a median of $923.3 million in 2024.
  • In the last 5 years, Conmed's Total Debt skyrocketed by 5406.6% in 2022 and then tumbled by 995.61% in 2025.
  • Over the past 5 years, Conmed's Total Debt (Quarter) stood at $684.7 million in 2021, then soared by 54.07% to $1.1 billion in 2022, then dropped by 7.68% to $973.8 million in 2023, then fell by 6.99% to $905.8 million in 2024, then dropped by 7.82% to $834.9 million in 2025.
  • Its last three reported values are $834.9 million in Q4 2025, $853.8 million for Q3 2025, and $881.8 million during Q2 2025.